Pulse Biosciences, Inc. (PLSE) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
PLSE Revenue Growth
Revenue Breakdown (FY 2022)
PLSE's revenue distribution by segment and geography for fiscal year 2022
By Product/Segment
By Geography
PLSE Revenue Analysis (2014–2025)
As of May 8, 2026, Pulse Biosciences, Inc. (PLSE) generated trailing twelve-month (TTM) revenue of $350,000. The most recent quarter (Q4 2025) recorded $264,000 in revenue, up 207.0% sequentially.
Looking at the longer-term picture, PLSE's historical revenue data shows a 3-year CAGR of -20.6%. The company achieved its highest annual revenue of $1.4 million in 2021.
Revenue diversification analysis shows PLSE's business is primarily driven by Cycle Units Products (100%). With over half of revenue concentrated in Cycle Units Products, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including INVA (+13.6% YoY), NVCR (+8.5% YoY), and ATEC (-7.4% YoY). Compare PLSE vs INVA →
PLSE Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| PLSECurrent | $350,000 | - | - | -21982.6% | |
 INVA | $425M | +13.6% | +4.8% | 38.5% | |
 NVCR | $655M | +8.5% | +5.8% | -23.5% | |
 ATEC | $764M | -7.4% | +39.5% | -10.7% | |
 ANAB | $235M | +157.0% | +25.6% | 20.4% | |
 INMD | $370M | -4.5% | +12.4% | 23.0% |
PLSE Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $350K | - | $-1,260,000 | -360.0% | $-76,939,000 | -21982.6% |
| 2024 | $0 | - | $0 | - | $-56,257,000 | - |
| 2023 | $0 | -100.0% | $-1,207,000 | - | $-43,574,000 | - |
| 2022 | $700K | -50.6% | $-11,244,000 | -1606.3% | $-58,057,000 | -8293.9% |
| 2021 | $1.4M | - | $-550,000 | -38.8% | $-63,014,000 | -4443.9% |
| 2020 | $0 | - | $-1,095,000 | - | $-49,965,000 | - |
| 2019 | $0 | - | $-666,000 | - | $-47,954,000 | - |
| 2018 | $0 | - | $-665,000 | - | $-37,963,000 | - |
| 2017 | $0 | - | $-665,000 | - | $-25,814,000 | - |
| 2016 | $0 | - | $-665,000 | - | $-9,586,000 | - |
See PLSE's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PLSE Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare PLSE vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonPLSE — Frequently Asked Questions
Quick answers to the most common questions about buying PLSE stock.
Is PLSE's revenue growth accelerating or slowing?
PLSE TTM revenue: $350000.00. YoY growth: N/A. 5-year CAGR: N/A.
What is PLSE's long-term revenue growth rate?
Pulse Biosciences, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is PLSE's revenue distributed by segment?
PLSE reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.